South East Asia and South Asia Industrial Microbiology Market, By Product Type (Equipment & system (filtration pumps & systems, microbial detection systems, air monitoring systems, incubators & culture apparatus, and others), reaction consumables (media (simple media, complex media, defined media, and specialty media), reagents & stains, and others), laboratory supply (bags & bottles, loop & needles, petrifies, racks, seals, plates & holders, sample preparation & collection, filtration discs and membranes, and others)), By Testing Type (sterility testing (open system, closed system, RTU bottles, DCM), bio-burden testing (membrane, funnels), environmental testing (RTU plates, DCM, hygiene monitoring in food, air samplers, compressed gas monitoring), pyrogen testing, pathogen testing (traditional method, rapid (platform)), and others), By End User (pharmaceuticals & biotechnology industry, government, academia, food and beverage industry, testing labs/commercial labs, and others), and By Region (South East Asia, and South Asia) is estimated to be valued at US$ 746.1 Mnin 2023 and is expected to exhibit a CAGR of 6% during the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.
Key market players are focusing on adopton of growth strategies such as launch of new products, and this is expected to drive the South East Asia and South Asia industrial microbiology market. For instance, in July 2021, Thermo Fisher Scientific, Inc., a biotechnology company, launched a first-in-market CO2 incubator that combines optimal cell growth capabilities with certified cleanroom compatibility, and thus, addressing the growing need among biotechnology, biopharmaceutical, and clinical labs for high-performance incubation systems that meet stringent cleanroom and cGMP standards.
South East Asia and South Asia Industrial Microbiology Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2019 as "coronavirus disease 2019" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems regarding the transportation of things from one place to another.
The coronavirus (COVID-19) pandemic and resulting lockdown in various countries across the globe has impacted the financial status of businesses in all sectors. The private healthcare sector is one of the sector, which has been majorly impacted by the COVID-19 pandemic. The pandemic had negatively impacted the South East Asia and South Asia industrial microbiology market by affecting directly on development, production, and supply of medical devices. It also affected growth of the pharmaceutical businesses of various companies globally, due to lockdowns implemented by governments of several countries. The nationwide lockdowns led to closure of industrial establishments, except manufacturing of essential commodities and disruption in supply chain of the pharmaceuticals and kits for diagnostic and therapeutic use. For instance, in September 2020, according to the article published by Frontiers S.A. Journal,, several animal processing plants were shut down in the U.S. in order to prevent the spread of the coronavirus infection. This led to the decrease in the rate of production of pharmaceutical products.
South East Asia and South Asia Industrial Microbiology Market: Key Developments
On June 29, 2023, Beckman Coulter Life Sciences, a leader in laboratory automation and innovation, launched a new Light Array Module (LAM) for the popular BioLector XT Microbioreactor. This advancement allows high-throughput screening and process optimization for a wide range of phototrophic organisms including microalgae and cyanobacteria. Utilizing real-time biomass, chlorophyll concentration, and fluorescence measurements, the BioLector XT Microbioreactor with LAM provides users real-time data without the need for pipetting samples for analysis.
On March 27, 2023, BIOMÉRIEUX, a biotechnology company, announced the partnership with Interscience, a developer of scientific instruments, to develop the 3P STATION, an automated system. This automated system is designed for the pharmaceutical industry to improve environmental monitoring.
On January 11, 2023, Becton, Dickinson and Company, a leading global medical technology company, introduced a new, robotic track system for the BD Kiestra microbiology laboratory solution that automates lab specimen processing, that can help to reduce manual labor and wait time for results. The new BD Kiestra 3rd Generation Total Lab Automation System allows laboratories to create a custom and flexible total lab automation configuration to connect multiple BD Kiestra modules and is scalable to meet labs' unique and evolving needs.
In August 2022, Beckman Coulter Life Sciences, a global leader in laboratory automation and biotechnology innovation, announced a partnership with Flownamics, a company offers products for bioprocess development and automation, to create an automated, on-line solution for bioprocess culture monitoring and control. This partnership provided critical and practical update to the significant unmet need for automated, real-time cell analysis in the bioprocessing environment.
Browse 37 Market Data Tables and 37 Figures spread through 210 Pages and in-depth TOC on “South East Asia and South Asia Industrial Microbiology Market,”- Forecast to 2030, South East Asia and South Asia Industrial Microbiology Market, By Product Type (equipment & system (filtration pumps & systems, microbial detection systems, air monitoring systems, incubators & culture apparatus, and others), reaction consumables (media (simple media, complex media, defined media, and specialty media), reagents & stains, and others), laboratory supply (bags & bottles, loop & needles, petrifies, racks, seals, plates & holders, sample preparation & collection, filtration discs and membranes, and others)), By Testing Type (sterility testing (open system, closed system, RTU bottles, DCM), bio-burden testing (membrane, funnels), environmental testing (RTU plates, DCM, hygiene monitoring in food, air samplers, compressed gas monitoring), pyrogen testing, pathogen testing (traditional method, rapid (platform)), and others), By End User (pharmaceuticals & biotechnology industry, government, academia, food and beverage industry, testing labs/commercial labs, and others), and By Region (South East Asia, and South Asia)
To know the latest trends and insights prevalent in this market, click the link below:
Key Takeaways of the South East Asia and South Asia Industrial Microbiology Market:
- South East Asia and South Asia industrial microbiology market is expected to exhibit a CAGR of 6% during the forecast period, owing to increasing organic growth strategies such as product launch by key market players to expand their product portfolio. For instance, in August 2021, The Baker Company, Inc. (Baker), a global leader in biosafety and contamination control technology, launched ReCO2verTM, an innovative, new "rapid recovery" cell culture incubator that brought more value to its customer in the field of microbiology, cell culture, and biological safety.
- Among product type, the equipment & system segment is expected to hold a dominant position in the South East Asia and South Asia industrial microbiology market during the forecast period owing to increasing organic growth strategies such product launch by key market players to expand their product portfolio. For instance, in May 2020, Esco Micro Pte. Ltd., a medical device company, announced the launch of Esco CelCulture CO2 Incubator with High Heat Sterilization (CCL-HHS). CCL-HHS is designed for high-quality incubation performance through precise control of heating and gas concentration combined with multiple contamination control and ergonomic features appropriate for safe incubation of many types of cells and tissues.
- Among end user, pharmaceuticals & biotechnology industry is expected to be the dominant segment in the South East Asia and South Asia industrial microbiology market, owing to increasing inorganic growth strategies such as acquisition to expand their product portfolio. For instance, in September 2022, Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, acquired ValitaCell Ltd. (“ValitaCell”), a biotechnology company that creates pioneering analytical products and technologies for the biopharmaceutical industry, to develop analytical technologies and products for the biopharmaceutical industry with the goal of reducing new therapeutics' cost and time to biopharmaceutical
- Major players operating in the South East Asia and South Asia industrial microbiology market are Merck KGaA., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Asiagel Corporation, Eppendorf AG, BioMérieux SA, Danaher Corporation, QIAGEN, Sartorius AG, 3M, HiMedia Laboratories Pvt. Ltd., Hygiena, LLC, Avantor, Inc., Advanced Diagnostic Laboratory (ADL), and BioLab Diagnostics India Private Limited
